Work

Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.567

Authors: Carissa Ellen Chu, Manuel De Jesus Escano, Wesley Yip, Song Jiang, Gopa Iyer, Hikmat A. Al-Ahmadie, Alvin C. Goh, Guido Dalbagni, Bernard H. Bochner, David B. Solit, Eugene J. Pietzak

Institutions: University of California, San Francisco, Memorial Sloan Kettering Cancer Center, University of Southern California

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4213153459

Cites:

Cited by: 4

Related to: 10